Auricularia: The Third-Most Cultivated Mushroom

Wood Ear Overview

17% of Global Production

Auricularia species account for approximately 17% of total global mushroom production, making them the third most cultivated edible fungi worldwide after Agaricus and Lentinula.

FAO/China Agriculture Statistics

7.7 Million Tons

annual production by 2022

90%+ from China

dominant global producer

40 Years of Research

since first antiplatelet study in 1982

FAO/China Agriculture Statistics

View as image ↗

Auricularia auricula, known as wood ear, black fungus, or Mo-er, is the third most cultivated edible mushroom in the world. Annual production reached 7.7 million tons by 2022, accounting for approximately 17% of global mushroom output. Despite this enormous production volume, the mushroom remains largely unknown outside of East Asian cuisine. In Western markets, it occupies a niche position in Asian grocery stores and hot-and-sour soups while commanding zero shelf space in mainstream supermarkets. This gap between production scale and Western awareness creates an information deficit: a mushroom consumed by billions lacks even basic public knowledge in much of the world.

For the naming confusion behind this mushroom, see Jew's ear, cloud ear, black fungus: understanding wood ear names. For traditional medical context, see Auricularia in traditional Chinese medicine: thousands of years of use.

Biology and Taxonomy

Auricularia is a genus of jelly fungi in the family Auriculariaceae, order Auriculariales. The most commercially important species are A. auricula-judae (wood ear, Jew's ear), A. polytricha (cloud ear), and A. cornea. Recent molecular taxonomy has revised some species boundaries, and what was historically called A. auricula in Chinese cultivation is now often classified as A. heimuer.

The fruiting bodies are ear-shaped, gelatinous, and translucent brown to dark brown, growing on dead or dying hardwood trees. Unlike the fleshy caps and gills of button mushrooms or shiitake, Auricularia has a rubbery, cartilaginous texture that absorbs flavors from cooking liquids. This texture, rather than any inherent flavor, is the primary culinary appeal. The mushroom is virtually tasteless on its own but provides a distinctive crunch and visual contrast in soups, stir-fries, and salads.

In the wild, Auricularia species are saprotrophs that decompose dead wood. They produce enzymes that break down lignin and cellulose, recycling nutrients back into forest ecosystems. This wood-decomposing capacity is the basis of commercial cultivation, which typically uses sawdust substrate in bags or wood log inoculation.

Global Production Scale

China dominates Auricularia production, accounting for more than 90% of global output. Production grew from 674,000 tons (dried weight) in 2018 to approximately 7.7 million tons (fresh weight) by 2022. The discrepancy between these figures reflects the conversion between dried and fresh weights: Auricularia is roughly 90% water when fresh.

Other significant producers include South Korea, Japan, Vietnam, Thailand, and Indonesia. In these countries, wood ear occupies a similar cultural position to button mushrooms in the West: a ubiquitous, affordable staple rather than a specialty item.

Western production is minimal. The United States, Europe, and Australia consume Auricularia primarily as an import, dried and packaged for Asian-cuisine applications. No large-scale Western cultivation operation has established Auricularia as a mainstream product, despite the mushroom's adaptability to temperate climates and relatively simple cultivation requirements.

Cultivation Methods

Traditional cultivation uses hardwood logs inoculated with Auricularia spawn. Logs are kept in humid, shaded conditions for 6 to 12 months until fruiting. This method produces high-quality fruiting bodies but is labor-intensive and limited by log availability.

Modern commercial production has shifted to substrate bag cultivation, using sawdust supplemented with wheat bran, rice bran, or cottonseed hulls. Bags are sterilized, inoculated, incubated until full colonization (typically 30-45 days), then moved to fruiting chambers with controlled humidity (85-95%), temperature (20-25 degrees C), and light exposure. Harvest occurs in multiple flushes over several weeks.

The substrate composition directly affects bioactive compound content. Studies have shown that substrate type influences polysaccharide yield, melanin content, and beta-glucan concentration. This variability means that two Auricularia products from different farms can have meaningfully different nutritional and bioactive profiles, a challenge for both consumers and researchers.

Nutritional Profile and Bioactive Compounds

Auricularia auricula is nutritionally distinct from other common mushrooms in several ways.

Dietary fiber. Wood ear has one of the highest dietary fiber contents among edible mushrooms, a property that underlies its prebiotic effects on gut microbiota. The polysaccharides resist human digestive enzymes and reach the colon intact, where they serve as fermentation substrate for beneficial bacteria.

Beta-glucans. Mirończuk-Chodakowska et al. (2017) measured 1,3-1,6-beta-D-glucan content across nine mushroom species and found Auricularia auricula-judae had the highest average content at 16.8 g/100g dry mass.^[1] This was nearly four times higher than cultivated Agaricus bisporus (cremini) at 3.9 g/100g. Beta-glucans are the compound class most associated with mushroom immunomodulatory effects.

Melanin. Auricularia contains substantial melanin pigments, which contribute its dark color and have demonstrated antioxidant activity in laboratory assays. Melanin content varies with growing conditions and strain.

Minerals. Wood ear is a dietary source of iron, calcium, potassium, and trace minerals. Iron content is frequently cited in traditional Chinese dietary therapy, though bioavailability data from controlled absorption studies are limited.

Acidic polysaccharides. Unlike many mushroom species whose active polysaccharides are neutral beta-glucans, Auricularia produces acidic polysaccharides rich in glucuronic acid. These acidic polysaccharides are the compounds responsible for the anticoagulant activity that distinguishes Auricularia from other medicinal mushrooms.

Research Landscape: Five Domains

Auricularia research spans five distinct domains, each with its own evidence base and maturity level. For a deeper look at the specific bioactive compounds, see wood ear bioactive compounds: polysaccharides, melanin, and minerals.

Blood and Cardiovascular Health

The longest-running research area, dating to Agarwal et al. (1982), who showed hot water extracts inhibited ADP-induced platelet aggregation in both human and rat platelets.^[2] Yoon et al. (2003) identified a 160 kDa acidic polysaccharide as the anticoagulant agent, with activity of 2 IU/mg mediated by antithrombin.^[3] Chen et al. (2011) showed ethanol extract reduced cholesterol and improved the atherosclerosis index in mice.^[4] For the full evidence, see Auricularia and thrombosis prevention and Auricularia and atherosclerosis prevention.

Gut Microbiome Modulation

Three studies using 16S rRNA sequencing showed Auricularia polysaccharides consistently increase Lactobacillus, Bacteroides, and Bifidobacterium while reducing harmful genera. Xu et al. (2021) demonstrated this effect at 50 and 100 mg/kg in diabetic mice, with concurrent improvements in glycolipid metabolism and gut microbiota diversity.^[5] The prebiotic effects connect to metabolic improvements through bile acid signaling and SCFA production. See Auricularia and gut microbiome modulation.

Blood Sugar and Diabetes

Research dating to Yuan et al. (1998) showed water-soluble polysaccharides lowered plasma glucose in genetically diabetic mice.^[6] Subsequent studies identified mechanisms including alpha-glucosidase inhibition, AKT/AMPK pathway activation, and gut microbiota-mediated metabolic improvement. See Auricularia and alpha-glucosidase inhibition.

Bone Health

Kim et al. (2024) discovered a biphasic effect: Auricularia water extract simultaneously inhibited RANKL-induced osteoclast formation (via ERK/JNK/c-Fos/NFATc1 suppression) and promoted BMP-2-stimulated osteoblast differentiation (via Smad/Runx2 activation).^[7] A peptide-calcium complex from Auricularia improved bone mineral density in disuse osteoporosis mice. See Auricularia and osteoblast differentiation.

Anti-inflammatory and Antioxidant Effects

Auricularia polysaccharides reduced oxidative stress markers (MDA, ROS) and inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) across multiple disease models. These effects are not isolated to one organ system but appear as a common thread running through the cardiovascular, gut, metabolic, and bone research.

Why the West Doesn't Know About It

Several factors explain the awareness gap:

Texture bias. Western palates generally prefer meaty, umami-rich mushroom textures. Auricularia's gelatinous, crunchy texture has no Western equivalent and triggers unfamiliarity rather than appetite.

Naming problems. The most common English name, "Jew's ear," is etymologically linked to Judas Iscariot and perceived as insensitive. "Wood ear" is neutral but nondescriptive. "Black fungus" sounds unappetizing to English speakers. None of these names market well.

Research origin. The overwhelming majority of Auricularia research is conducted in China, South Korea, and Japan. Western pharmaceutical and nutraceutical companies have not invested in Auricularia-specific product development, partly because the mushroom lacks the dramatic marketing story of reishi ("mushroom of immortality") or lion's mane ("the brain mushroom").

No supplement marketing push. Unlike reishi, chaga, or lion's mane, Auricularia has not been adopted by the Western supplement industry as a headline product. Without marketing investment, consumer awareness remains minimal.

Culinary accessibility. In Asian markets, fresh or dried wood ear is sold alongside everyday vegetables. In Western markets, it requires a trip to a specialty store and recipe knowledge that most home cooks lack. The dried form, which requires soaking and looks unfamiliar, creates an additional barrier compared to mushrooms that can be sauteed from fresh.

Limitations of the Evidence

Despite 40 years of research and massive global production, several critical limitations persist:

Zero human clinical trials for any health endpoint. Every study cited in this article and across the Auricularia research literature used rodent models or cell culture. Not a single randomized controlled trial has tested Auricularia for cardiovascular, metabolic, bone, or gut outcomes in humans.

The food-extract gap. Most studies use purified polysaccharide fractions or concentrated extracts at defined doses. Whether consuming whole wood ear mushroom in dietary quantities delivers pharmacologically relevant amounts of active compounds is unknown.

Species confusion. The genus Auricularia contains multiple species with different chemical profiles. Studies using A. auricula-judae, A. polytricha, A. cornea, and A. heimuer are sometimes grouped together, obscuring species-specific differences.

Production standardization. Bioactive compound content varies with substrate, cultivation conditions, harvest timing, and processing methods. No standardized preparation exists for research purposes, making cross-study comparisons difficult.

The Bottom Line

Auricularia auricula is one of the world's most produced mushrooms, with 7.7 million tons annually and consumption spanning millennia in East Asia. Its polysaccharides, particularly acidic fractions rich in glucuronic acid, drive a research profile that includes anticoagulant activity, gut microbiome modulation, blood sugar regulation, cholesterol reduction, and bone health effects. The beta-glucan content is among the highest of any edible mushroom tested. Despite this broad preclinical evidence base built over 40 years, no human clinical trials have been completed for any health endpoint. The gap between Auricularia's massive production scale in Asia and near-total obscurity in Western markets represents both a knowledge deficit and a research opportunity.

Frequently Asked Questions

What is Auricularia auricula mushroom?

Auricularia auricula (wood ear, black fungus, Mo-er) is a jelly fungus that grows on dead hardwood trees. It is the third most cultivated mushroom worldwide, with annual production of approximately 7.7 million tons, over 90% from China. The ear-shaped, gelatinous fruiting body is widely used in East Asian cuisine for its distinctive crunchy texture. It contains high levels of dietary fiber, beta-glucans (16.8 g/100g dry mass), melanin, and acidic polysaccharides with anticoagulant properties (Mirończuk-Chodakowska et al., 2017).

Is wood ear mushroom good for you?

Preclinical research suggests wood ear has several health-relevant properties. Its polysaccharides modulate gut microbiota composition, increasing beneficial bacteria like Lactobacillus and Bacteroides (Xu et al., 2021). Acidic polysaccharides show anticoagulant activity comparable to aspirin in rat platelet tests (Yoon et al., 2003). Ethanol extracts reduce cholesterol in mice (Chen et al., 2011). However, all evidence comes from animal studies and cell culture. No human clinical trials have been completed for any health endpoint.

Why is wood ear mushroom not popular in the West?

Several factors limit Western adoption. Its gelatinous, crunchy texture has no Western culinary equivalent and triggers unfamiliarity. Common English names are problematic: "Jew's ear" is perceived as insensitive, "black fungus" sounds unappetizing, and "wood ear" is nondescriptive. The Western supplement industry has not invested in Auricularia marketing, unlike reishi or lion's mane. Most research originates from Chinese and Korean institutions without equivalent Western pharmaceutical interest.

How much wood ear mushroom is produced globally?

Auricularia species account for approximately 17% of global mushroom production, making them the third most cultivated edible fungi after Agaricus (button mushrooms) and Lentinula (shiitake). Annual production reached approximately 7.7 million tons by 2022. China produces over 90% of the global supply. Other producers include South Korea, Japan, Vietnam, Thailand, and Indonesia. Western production is minimal, with most consumption from imported dried products.

What are the bioactive compounds in wood ear mushroom?

Wood ear contains several bioactive compound classes. Acidic polysaccharides (rich in mannose and glucuronic acid) show anticoagulant and antiplatelet activity (Yoon et al., 2003). 1,3-1,6-beta-D-glucans (16.8 g/100g dry mass) are immunomodulatory compounds (Mirończuk-Chodakowska et al., 2017). Polyphenolic compounds drive cholesterol-lowering effects independent of polysaccharides (Chen et al., 2011). Melanin pigments have antioxidant properties. The mushroom also contains dietary minerals including iron and calcium.

What health benefits does wood ear mushroom have?

Preclinical research identifies five domains of activity: anticoagulant and antiplatelet effects (Agarwal et al., 1982; Yoon et al., 2003), gut microbiome modulation with increased beneficial bacteria (Xu et al., 2021), blood sugar regulation in diabetic mice (Yuan et al., 1998), cholesterol reduction (Chen et al., 2011), and bone health through simultaneous osteoblast promotion and osteoclast inhibition (Kim et al., 2024). All evidence is from animal studies. No human clinical trials have tested wood ear for any health outcome.

Sources & References

1. 1RTHM-00484·Mirończuk-Chodakowska, Iwona et al. (2017). “Quantitative evaluation of 1,3,1,6 β-D-glucan contents in wild-growing species of edible Polish mushrooms..” Roczniki Panstwowego Zakladu Higieny.Study breakdown →PubMed →↩
2. 2RTHM-00002·Agarwal, K C et al. (1982). “Inhibition of human and rat platelet aggregation by extracts of Mo-er (Auricularia auricula)..” Thrombosis and haemostasis.Study breakdown →PubMed →↩
3. 3RTHM-00065·Yoon, Seon-Joo et al. (2003). “The nontoxic mushroom Auricularia auricula contains a polysaccharide with anticoagulant activity mediated by antithrombin..” Thrombosis research.Study breakdown →PubMed →↩
4. 4RTHM-00208·Chen, Gang et al. (2011). “Hypocholesterolemic effects of Auricularia auricula ethanol extract in ICR mice fed a cholesterol-enriched diet..” Journal of food science and technology.Study breakdown →PubMed →↩
5. 5RTHM-00728·Xu, Nuo et al. (2021). “Auricularia auricula-judae (Bull.) polysaccharides improve type 2 diabetes in HFD/STZ-induced mice by regulating the AKT/AMPK signaling pathways and the gut microbiota..” Journal of food science.Study breakdown →PubMed →↩
6. 6RTHM-00028·Yuan, Z et al. (1998). “Hypoglycemic effect of water-soluble polysaccharide from Auricularia auricula-judae Quel. on genetically diabetic KK-Ay mice..” Bioscience.Study breakdown →PubMed →↩
7. 7RTHM-00885·Kim, Shin-Hye et al. (2024). “The Biphasic Activity of Auricularia Auricula-Judae Extract on Bone Homeostasis through Inhibition of Osteoclastogenesis and Modulation of Osteogenic Activity..” Journal of microbiology and biotechnology.Study breakdown →PubMed →↩